insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21.

European urology open science 2026 Vol.84() p. 60-61

Achard V, Zilli T, Tombal B

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Achard V, Zilli T, Tombal B (2026). Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21.. European urology open science, 84, 60-61. https://doi.org/10.1016/j.euros.2026.01.001
MLA Achard V, et al.. "Re: Amar U. Kishan, Luca F. Valle, Holly Wilhalme, et al. Lu-Prostate-specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-label, Randomized, Controlled, Phase II Study. J Clin Oncol 2025;43:3812-21.." European urology open science, vol. 84, 2026, pp. 60-61.
PMID 41631038
DOI 10.1016/j.euros.2026.01.001

같은 제1저자의 인용 많은 논문 (3)